1.
Cerbelli B, Marletta S, Amato M, Campora M, Costarelli L, Errigo V, Ferraro G, Foschini MP, Franco R, Fusco N, Marchetti A, Mastropasqua MG, Orvieto E, Pietribiasi F, Ragazzi M, Rizzo A, Santinelli A, Zanconati F, d’Amati G, Scatena C, Castellano I. Standardizing the pathologic assessment of HER2-Low and HER2-Ultralow breast cancer: Insights from a national Italian project. Pathologica [Internet]. 2026 Feb. 6 [cited 2026 Feb. 7];117(6). Available from: https://www.pathologica.it/article/view/1565